Results 201 to 210 of about 72,161 (311)
Recognition of precursor proteins by the mitochondrial protein import apparatus [PDF]
Becker, Karin +3 more
core +1 more source
The incretin system in healthy humans: The role of GIP and GLP-1.
J. Holst
semanticscholar +1 more source
ABSTRACT Vildagliptin (VDG) is a dipeptidyl‐peptidase‐4 (DPP‐4) inhibitor used for type 2 diabetes (T2DM) treatment. Viewing to improve VDG treatment, a population pharmacokinetic (popPK) model was built to describe drug plasma, free liver and muscle concentrations determined by microdialysis in healthy and diabetic animals following 50 mg/kg i.v ...
Bruna Bernar Dias +2 more
wiley +1 more source
Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain. [PDF]
Jackson SE +4 more
europepmc +1 more source
The Seplife Fmoc‐RinkAmide‐PS‐PEG resin, a PEG‐grafted PS resin with optimized composition enables improved swelling and higher loading for SPPS. This resin delivers efficient couplings and high crude purities, supporting reliable synthesis of long and complex peptides.
Ashish Kumar +12 more
wiley +1 more source
Decreased risk of post-thyroidectomy hypocalcemia with history of GLP-1RA use. [PDF]
Ayo-Ajibola O +6 more
europepmc +1 more source
Who Wins the Battle Against Obesity? A Network Meta‐Analysis Comparing Tirzepatide and Semaglutide
Network meta‐analysis comparing the effects of tirzepatide, semaglutide, and placebo on body weight reduction and glycemic outcomes in adults with overweight or obesity. ABSTRACT Introduction Pharmacological therapies are recommended for individuals with obesity.
Julia C. Bernardi +7 more
wiley +1 more source
GLP-2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. [PDF]
Galsgaard KD +5 more
europepmc +1 more source
Nineteen international endocrinologists support fenofibrate use to prevent diabetic retinopathy progression and emphasize the need for coordinated care pathways and early intervention to improve diabetic retinopathy management globally. ABSTRACT Background Diabetic retinopathy remains a leading cause of preventable blindness worldwide, yet screening ...
Richard C. O'Brien +9 more
wiley +1 more source

